Latest News & Features
Americas
New England Biolab contends plaintiff’s patents are invalid and cover “unpatentable natural processes”| Biomodal had accused rival of infringing several patents covering methods to detect and modify DNA methylatian—a key part of epigenetic research 28 November 2024
Americas
Key similarities and differences between the patent systems, particularly in biotech, offer lessons and opportunities for rightsholders, say Daniela Fasoli of Simões Propriedade Intelectual and Jeffrey Morton of Haynes and Boone. 28 November 2024
Americas
Wholesaler ‘bought nearly 17,000 bottles of fake Gilead drugs’ | US government says defendant sentenced in September should pay company for lost profits. 26 November 2024
Europe
European panel deals blow to a biotech company over human milk oligosaccharides used in infant formula | Patent opposed by giant Nestlé, FrieslandCampina, and Danisco questioning its inventive step. 26 November 2024
Asia
Agreement provides for €140 million in upfront and additional payments to Cytokinetics and up to €490 million in milestone payments, with tiered royalties on future sales | “Important regional deal” comes as Bayer’s new partner eyes US and European markets. 21 November 2024
Europe
European Patent Office deals blow to pharma companies in dismissing their attempts to reinstate patents covering diabetes and obesity treatments | Inhibrx antibody patent upheld as Gilead subsidiary appeal is rejected. 21 November 2024
Careers
Firm appoints Craig Bleifer as a partner in its New York office | Bleifer brings more than three decades of experience, including senior roles at Novo Nordisk and Daiichi Sankyo. 21 November 2024
Careers
The firm brings two life sciences and tech experts to its litigation department | Pair bring combined experience of 45 years from Weil, Gotshal & Manges | Duo offer expertise handling cases for pharmaceutical, biotechnology, and technology clients. 21 November 2024
Americas
Judges at Munich Local Division determined that Meril infringed Edwards Lifesciences’ patent | Meril ordered to stop selling and recall product as well as pay damages. 19 November 2024
Americas
US Supreme Court blocks bid to overturn lower court ruling | District court found in 2023 that the generic would infringe patents owned by a Bausch subsidiary | Blockbuster drug Xifaxan is used to treat IBS with diarrhoea, and a liver-related brain disorder. 19 November 2024